Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Levovist]

S Beppu1

  • 1School of Allied Health Sciences, Faculty of Medicine, Osaka University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 13, 1998
PubMed
Summary
This summary is machine-generated.

SH/TA-508, a microbubble ultrasound contrast agent, enhances cardiac and organ imaging. This galactose-based agent improves diagnostic capabilities in clinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymph node density predicts lung metastases in oral squamous cell carcinoma.

The British journal of oral & maxillofacial surgery·2015
Same author

Serial assessment of left and right ventricular filling in patients with congestive heart failure.

Japanese circulation journal·2001
Same author

[On line display of the reconstructed pressure waves of the radial artery from the monitored output pressure waves at the same site].

Masui. The Japanese journal of anesthesiology·2001
Same author

[Effect of oxygen inhalation on myocardial opacification using levovist: an animal experimental study].

Journal of cardiology·2001
Same author

[Optimal setting of focus points for myocardial contrast echocardiography with intravenous Optison (FS-69): an experimental study].

Journal of cardiology·2001
Same author

[Usefulness of intravenous myocardial contrast echocardiography in rats].

Journal of cardiology·2001
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biomedical Engineering
  • Diagnostic Imaging
  • Materials Science

Context:

  • Ultrasound contrast agents are crucial for enhancing diagnostic imaging.
  • SH/TA-508 (Levovist) is a novel microbubble contrast agent composed of galactose and palmitic acid.
  • Microbubbles are stabilized by palmitic acid, forming agglomerates of microparticles.

Purpose:

  • To evaluate the efficacy and characteristics of SH/TA-508 as an ultrasound contrast agent.
  • To assess the opacification of cardiac structures and blood flow using SH/TA-508.
  • To investigate the enhancement of microcirculatory flow in various organs.

Summary:

  • SH/TA-508 microbubbles are stable under high pressure and circulate in the bloodstream for minutes post-injection.
  • The contrast agent clearly opacifies left-sided cardiac cavities and arteries.

Related Experiment Videos

  • Significant enhancement of Doppler signals from mitral, aortic, and pulmonic veins was observed.
  • Clinical studies demonstrated well-enhanced microcirculating flow images of the liver, kidney, and other organs.

    • Impact:

    • SH/TA-508 significantly improves the diagnostic capabilities of ultrasound.
    • Enhanced visualization of cardiac and organ microcirculation aids in clinical diagnosis.
    • This agent offers a valuable tool for advanced ultrasound diagnostics.